Skip to main content
. 2022 Oct 18;22(4):6. doi: 10.5334/ijic.6473

Table 1.

Study Characteristics.


TRIAL DURATION AND FOLLOW-UP STUDY PARTICIPANTS SETTING CONTROL INTERVENTION MDT MEETING DESCRIPTION OUTCOMES RESULTS

Counsell et al 2007 [25] Intervention: 24 months
Follow-up: 6, 12, 18 and 24 months
Aged ≥ 65, Annual income 200% < federal poverty level, comorbidities (n = 951) Primary care practice serving approximately 6000 patients Usual care
(n = 477)
Geriatric care management model: GRACE intervention
(n = 474)
Weekly interdisciplinary team meetings (nurse practioner, social worker, primary care physician) to review support team success in implementing care protocols and problem solve barriers to implementation Physical health,
Function health,
Utilisation of health services,
  • Improved scores in 4/8 components of the SF-36 in intervention group participants compared to standard care

  • No differences observed in ADL scores between intervention group and standard care

  • Mortality rate is reduced in the intervention group in comparison to standard care

  • Hospitalisation and ED visits were lower in intervention group participants in the last 12 months of the trial,


Harpole et al 2005 [26] Intervention: 12 months
Follow-up: 3, 6, 12 months
Aged ≥ 60,
Major depression or dysthymia and ≥ 1 other chronic condition.
(n = 1801)
18 primary care clinics Usual care
(n = 895)
IMPACT intervention
(n = 906)
The district care nurse met weekly with the supervising psychiatrist and the liaison primary care physician to monitor progress and adjust treatment plans as needed Mental health,
Functional health
  • Significantly lowerSCL-30 depression scores in intervention patients compared to usualcare

  • Improved MCS-12 scores at the 3- and 12- month interval in intervention group participants, in comparison to standardcare

  • Improved scores of quality of life in the interventiongroup compared to those that received standard care


Katon et al 2010/2012 [23,24] Intervention: 24 months
Follow-up: 6, 12, 18, 24 months
Depression and diabetes, or coronary heart disease, or both
(n = 214)
14 primary care clinics Enhanced usual care
(n = 108)
TEAMcare program
(n = 106)
Nurses met weekly for systematic case reviews with the family physician, consulting psychiatrist and internist, to enhance care coordination and ensure accountability for follow-up to guideline level disease management and achieve clinical goals Physical health,
Mental health,
Functional health,
Provider behaviour,
Acceptability of services,
Costs and cost-effectiveness
  • Improved LDL cholesterol levels, systolic bloodpressure 12 months, but the intervention group displayed no differencesat the 18- and 24 months interval

  • Improved SCL-20scores within intervention participants

  • The intervention group participants had 114additional depression-free days and an additional 0.335 QALYS

  • Morelikely to have drug adjustments

  • Intervention group participants experienced agreater satisfaction with their care in comparison to patients whoreceived standard care

  • The intervention was cost-effective


Sommers et al 2000 [27] Intervention: 24 months
Follow-up: 12 months post-intervention
Aged > 65,
≥ 2 chronic conditions
(n = 543)
18 primary care clinics Usual care
(n = 263)
Collaborative Care
(n = 280)
The physician, the nurse and the social worker met at least monthly to review each patient’s status and revise care plans. Physical health,
Functional health,
Utilisation of health services,
Costs and cost-effectiveness
  • Improved hospitalisation rate, mean primary care physician officevisits among the intervention group participants in comparison to thosewho received usual care

  • Increase in social activity

  • The interventionwas cost-effective


Abbreviations: SF-36; short form survey 36, MDT; multidisciplinary team, ADL; activities of daily living, ED; emergency department, SCL-30; check list of symptoms 30, GRACE; geriatric resources for the assessment and care of elders, IMPACT; improving mood-promoting access to collaborative treatment, LDL; low-density lipoprotein, n; number of participants.